Benjamin S Aribisala Selected Research

HDL Cholesterol

1/2017

Interaction of APOE e4 and poor glycemic control predicts white matter hyperintensity growth from 73 to 76.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Benjamin S Aribisala Research Topics

Disease

1	Type 2 Diabetes Mellitus (MODY) 10/2018
1	Dementia (Dementias) 01/2017
1	Hypercholesterolemia 01/2017
1	Hypertension (High Blood Pressure) 01/2017
1	Inflammation (Inflammations) 02/2014
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 11/2009
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 04/2009
1	Fatigue 04/2009

Drug/Important Bio-Agent (IBA)

1	Apolipoproteins E (ApoE)IBA 01/2017
1	ApolipoproteinsIBA 01/2017
1	HDL LipoproteinsIBA 01/2017
1	HDL CholesterolIBA 01/2017
1	Prednisolone (Predate)FDA LinkGeneric 02/2014
1	GadoliniumIBA 11/2009
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2009
1	ManganeseIBA 04/2009

Therapy/Procedure

1	Glycemic Control 10/2018